New Mobile App Assists Oncologists In Navigating Ever-Evolving Sea Of Cancer Information

barbara.lempert

Lilly Oncology partners with MDLinx to make new research easily accessible

INDIANAPOLIS, May 31, 2013 /PRNewswire/ — Recent advancements in research have come at break-neck speed, yielding data that has provided new hope for patients. Each advancement comes with an accompanying manuscript and are presented, each day, with dozens of newly published peer-reviewed, -related articles in order to keep up to date on the latest advances. To aid physicians and researchers, Eli Lilly and Company (NYSE: LLY) announced an exclusive sponsorship of MDLinx, a web property of M3 USA, for a searchable application that provides reviews of the latest oncology-specific journal articles.

The journal aggregator app, called MDLinx Oncology Articles, is available for Google Android® and Apple iPhone® platforms and allows users to access the oncology that is most important to them wherever they may be. Physician editors at MDLinx rank, sort and summarize oncology articles from more than 150 oncology journals, allowing oncologists to not only choose what journals they want to follow and filter by sub-specialty, but also search articles by key term or tumor type. The content is selected and controlled exclusively by the MDLinx Editorial Team at M3.

The new app is being launched today at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago, Ill., to more than 25,000 oncology professionals.

“This sponsorship was an easy decision for Lilly Oncology,” said Richard Gaynor, M.D., vice president of product development and medical affairs for Lilly Oncology. “This app offers users the latest updates in the oncology field without having to visit multiple online journal sites. It also allows oncologists to personalize how they get relevant clinical updates which they can apply to their approach with patients in real time.”

Similar to other news-source applications, the content is updated…Read more

Pharmalive – The Pulse of the Pharmaceutical Industry

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS